Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Mercury Pharma International Ltd, 4045, Kingswood Road, City West Business Park, Co Dublin, Ireland
Haloperidol 5mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solution for Injection. Clear, colourless sterile solution |
Each ml of solution contains Haloperidol 5mg.
Excipient with known effect: Contains sodium less than 1mmol per dose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Haloperidol |
Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity. |
| List of Excipients |
|---|
|
Lactic acid |
1ml & 2 ml clear One Point Cut (OPC) glass ampoules, glass type 1 Ph. Eur. borosilicate glass packed in cardboard cartons to contain 10x1ml ampoules and 10x2ml ampoules.
Not all pack sizes may be marketed.
Mercury Pharma International Ltd, 4045, Kingswood Road, City West Business Park, Co Dublin, Ireland
PL 02848/0127
Date of first authorisation: 27/9/89
Date of last renewal: 18/7/2008
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
